BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37651277)

  • 1. Imaging Findings in Cirrhotic Liver: Pearls and Pitfalls for Diagnosis of Focal Benign and Malignant Lesions.
    Liu X; Tan SBM; Awiwi MO; Jang HJ; Chernyak V; Fowler KJ; Shaaban AM; Sirlin CB; Furlan A; Marks RM; Elsayes KM
    Radiographics; 2023 Sep; 43(9):e230043. PubMed ID: 37651277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.
    Renzulli M; Brandi N; Argalia G; Brocchi S; Farolfi A; Fanti S; Golfieri R
    Radiol Med; 2022 Feb; 127(2):129-144. PubMed ID: 35028886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
    Galia M; Taibbi A; Marin D; Furlan A; Dioguardi Burgio M; Agnello F; Cabibbo G; Van Beers BE; Bartolotta TV; Midiri M; Lagalla R; Brancatelli G
    Diagn Interv Radiol; 2014; 20(3):222-8. PubMed ID: 24509186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver.
    Renzulli M; Brocchi S; Ierardi AM; Milandri M; Pettinari I; Lucidi V; Balacchi C; Muratori P; Marasco G; Vara G; Tovoli F; Granito A; Carrafiello G; Piscaglia F; Golfieri R
    Magn Reson Imaging; 2021 Jan; 75():9-20. PubMed ID: 32926993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
    Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
    Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.
    Darnell A; Rimola J; Belmonte E; Ripoll E; Garcia-Criado Á; Caparroz C; Díaz-González Á; Vilana R; Reig M; Ayuso C; Bruix J; Forner A
    Eur Radiol; 2021 Jul; 31(7):4794-4803. PubMed ID: 33409789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Primary Liver Cancers Using Hepatocyte-Specific Contrast-Enhanced MRI: Pitfalls and Potential Tips.
    Kim JH; Yoon JH; Joo I; Lee JM
    J Magn Reson Imaging; 2021 Mar; 53(3):655-675. PubMed ID: 32700807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
    Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
    World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging findings of mimickers of hepatocellular carcinoma.
    Kim TK; Lee E; Jang HJ
    Clin Mol Hepatol; 2015 Dec; 21(4):326-43. PubMed ID: 26770920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasound pattern of hepatocellular carcinoma in noncirrhotic liver - results from the prospective multicentre DEGUM CEUS HCC study.
    Schellhaas B; Jesper D; Strobel D;
    Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):313-319. PubMed ID: 36708302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
    Kim JH; Joo I; Lee JM
    Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal lesions in cirrhosis: Not always HCC.
    Ronot M; Dioguardi Burgio M; Purcell Y; Pommier R; Brancatelli G; Vilgrain V
    Eur J Radiol; 2017 Aug; 93():157-168. PubMed ID: 28668410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.
    Kovac JD; Ivanovic A; Milovanovic T; Micev M; Alessandrino F; Gore RM
    Radiol Oncol; 2021 Jan; 55(2):130-143. PubMed ID: 33544992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.
    Kovac JD; Milovanovic T; Dugalic V; Dumic I
    World J Gastroenterol; 2020 May; 26(17):2012-2029. PubMed ID: 32536771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.
    Kovač JD; Janković A; Đikić-Rom A; Grubor N; Antić A; Dugalić V
    Curr Oncol; 2022 Jan; 29(2):698-723. PubMed ID: 35200560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study.
    Seitz K; Greis C; Schuler A; Bernatik T; Blank W; Dietrich CF; Strobel D
    Ultraschall Med; 2011 Dec; 32(6):598-603. PubMed ID: 22161557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
    Huang B; Wu L; Lu XY; Xu F; Liu CF; Shen WF; Jia NY; Cheng HY; Yang YF; Shen F
    Radiology; 2016 Oct; 281(1):150-7. PubMed ID: 27077381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.